About this trial
The purpose of this study is to assess the effectiveness of a "Food is Medicine" (FIM) intervention on incidence of gestational diabetes mellitus (GDM) among pregnant women at risk for GDM within the Harris Health system.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
pregnant women receiving care at Harris Health clinics
Medicaid eligible or receiving Medicaid
<=14 weeks gestation at the time of the first prenatal visit and study enrollment
meet the ACOG criteria for early screening for GDM (have a BMI of 30 or greater and at least one additional ACOG-designated risk factor for GDM from the following: Age > 35 years; Black, Hispanic, Native American, Asian American or Pacific Islander ethnicity; history of GDM in prior pregnancy; A1c level > 5.7 & < 6.4; history of hypertension, pregnancy hypertension, heart disease, HIV, high triglycerides, polycystic ovarian syndrome; Immediate family member (parent or sibling) has had diabetes)
Disqualifiers
report existing or pregestational T2DM
have hemoglobin A1c>=7
are prescribed insulin therapy or metformin upon first screening
Trial design
Parallel
Treatments tested in this trial
Food is Medicine (FIM) Intervention
BehavioralIntensive intervention phase - this phase starts at enrollment (\<=14 weeks) through 28 weeks of gestation (or at the time of GDM diagnostic test) and women i) receive a bi-weekly home delivery of a "mixed box" consisting of fresh produce, lean protein, and whole grains combined with culinary medicine-based nutrition education available in English and Spanish. Maintenance phase - this phase starts at 29 weeks through 12 weeks postpartum, and women will receive biweekly deliveries of about 10-15 pounds of fresh produce (8-10 different kinds of produce) plus standard nutrition education. The box will be curated for prenatal nutrients needs and following American Diabetes Association guidelines.
Standard of Care
BehavioralStandard medical care provided at Harris Health for high-risk pregnant women, plus a voucher equal to the value of the produce and meals provided in the Food is Medicine (FIM) Intervention.
Treatment groups
Trial outcomes
Primary outcomes
Number of participants with gestational diabetes mellitus (GDM)
Secondary outcomes
Number of participants with hypertensive disorders of pregnancy
Number of infants with macrosomia at birth
Number of infants with pre-term birth
Number of infants born via C-section
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: